Improved prediction of sudden cardiac death in patients with heart failure through digital processing of electrocardiography

Author:

Shiraishi Yasuyuki1ORCID,Goto Shinichi2ORCID,Niimi Nozomi1ORCID,Katsumata Yoshinori3ORCID,Goda Ayumi4ORCID,Takei Makoto5ORCID,Saji Mike6ORCID,Sano Motoaki1,Fukuda Keiichi1ORCID,Kohno Takashi4ORCID,Yoshikawa Tsutomu6,Kohsaka Shun1ORCID

Affiliation:

1. Department of Cardiology, Keio University School of Medicine , 35 Shinanomachi Shinjuku-ku, Tokyo 160-8582 , Japan

2. One Brave Idea and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital , Boston, MA , USA

3. Institute for Integrated Sports Medicine, Keio University School of Medicine , Tokyo , Japan

4. Department of Cardiovascular Medicine, Kyorin University Faculty of Medicine , Tokyo , Japan

5. Department of Cardiology, Saiseikai Central Hospital , Tokyo , Japan

6. Department of Cardiology, Sakakibara Heart Institute , Tokyo , Japan

Abstract

AbstractAimsAvailable predictive models for sudden cardiac death (SCD) in heart failure (HF) patients remain suboptimal. We assessed whether the electrocardiography (ECG)-based artificial intelligence (AI) could better predict SCD, and also whether the combination of the ECG-AI index and conventional predictors of SCD would improve the SCD stratification among HF patients.Methods and resultsIn a prospective observational study, 4 tertiary care hospitals in Tokyo enrolled 2559 patients hospitalized for HF who were successfully discharged after acute decompensation. The ECG data during the index hospitalization were extracted from the hospitals’ electronic medical record systems. The association of the ECG-AI index and SCD was evaluated with adjustment for left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) class, and competing risk of non-SCD. The ECG-AI index plus classical predictive guidelines (i.e. LVEF ≤35%, NYHA Class II and III) significantly improved the discriminative value of SCD [receiver operating characteristic area under the curve (ROC-AUC), 0.66 vs. 0.59; P = 0.017; Delong’s test] with good calibration (P = 0.11; Hosmer–Lemeshow test) and improved net reclassification [36%; 95% confidence interval (CI), 9–64%; P = 0.009]. The Fine–Gray model considering the competing risk of non-SCD demonstrated that the ECG-AI index was independently associated with SCD (adjusted sub-distributional hazard ratio, 1.25; 95% CI, 1.04–1.49; P = 0.015). An increased proportional risk of SCD vs. non-SCD with an increasing ECG-AI index was also observed (low, 16.7%; intermediate, 18.5%; high, 28.7%; P for trend = 0.023). Similar findings were observed in patients aged ≤75 years with a non-ischaemic aetiology and an LVEF of >35%.ConclusionTo improve risk stratification of SCD, ECG-based AI may provide additional values in the management of patients with HF.

Funder

Japanese Circulation Society

SECOM Science and Technology Foundation

Uehara Memorial Foundation

Grant-in-Aid for Young Scientists

Grant-in-Aid for Scientific Research

Japan Agency for Medical Research and Development

Sakakibara Clinical Research Grants for the Promotion of Science

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Heart disease and stroke statistics—2021 update: a report from the American Heart Association;Virani;Circulation,2021

2. Epidemiology of heart failure in Asia;Sato;Heart Fail Clin,2015

3. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

4. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Heidenreich;Circulation,2022

5. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program;Solomon;Circulation,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3